BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25150639)

  • 1. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.
    Kundu SD; Feldman DR; Carver BS; Gupta A; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J
    J Urol; 2015 Feb; 193(2):513-8. PubMed ID: 25150639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors.
    McHugh DJ; Funt SA; Silber D; Knezevic A; Patil S; O'Donnell D; Tsai S; Reuter VE; Sheinfeld J; Carver BS; Motzer RJ; Bajorin DF; Bosl GJ; Feldman DR
    J Clin Oncol; 2020 Apr; 38(12):1332-1337. PubMed ID: 32109195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of adjuvant chemotherapy in testicular cancer.
    Bernstein JI; Freiha F; Breeden J; Torti FM
    Cancer; 1987 Oct; 60(8):1729-30. PubMed ID: 2443231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
    Calaway AC; Foster RS; Adra N; Masterson TA; Albany C; Hanna NH; Einhorn LH; Cary C
    J Clin Oncol; 2018 Oct; 36(29):2950-2954. PubMed ID: 30156983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.
    Funt SA; McHugh DJ; Tsai S; Knezevic A; O'Donnell D; Patil S; Silber D; Bromberg M; Carousso M; Reuter VE; Carver BS; Sheinfeld J; Motzer RJ; Bajorin DF; Bosl GJ; Feldman DR
    Oncologist; 2021 Jun; 26(6):483-491. PubMed ID: 33586274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of surgery after chemotherapy for advanced germ cell tumors.
    Freiha FS; Shortliffe LD; Rouse RV; Mark JB; Hannigan JF; Aston D; Spaulding JT; Williams RD; Torti FM
    J Urol; 1984 Nov; 132(5):915-7. PubMed ID: 6208386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of post-chemotherapy extra-retroperitoneal residual masses.
    Carver BS; Sheinfeld J
    World J Urol; 2009 Aug; 27(4):489-92. PubMed ID: 19373472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Survival of Good-Risk Germ Cell Tumor Patients After Postchemotherapy Retroperitoneal Lymph Node Dissection: A Comparison of BEP × 3 vs. EP × 4 and Treating Institution.
    Cary C; Jacob JM; Albany C; Masterson TA; Hanna NH; Einhorn LH; Foster RS
    Clin Genitourin Cancer; 2018 Apr; 16(2):e307-e313. PubMed ID: 29104087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
    Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
    J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of teratoma of the testis with retroperitoneal lymph nodes involved with malignant teratoma after chemotherapy].
    Muraki J; Nakazono M
    Nihon Hinyokika Gakkai Zasshi; 1993 Dec; 84(12):2162-5. PubMed ID: 7508531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aortic replacement during post chemotherapy retroperitoneal residual tumor resection for nonseminomatous germ cell tumor: a case report].
    Matsuzaki M; Nakano M; Komatsu H; Ohashi K
    Hinyokika Kiyo; 2005 Dec; 51(12):831-4. PubMed ID: 16440734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses.
    Oldenburg J; Alfsen GC; Lien HH; Aass N; Waehre H; Fossa SD
    J Clin Oncol; 2003 Sep; 21(17):3310-7. PubMed ID: 12947067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis.
    Nitta S; Kawai K; Kimura T; Kandori S; Kawahara T; Kojima T; Nishiyama H
    Int J Urol; 2021 Aug; 28(8):840-847. PubMed ID: 34085325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.